Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 712737 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Search Results

Your Search for 'Commercial Insight: Infectious Diseases Overview' returned 82 results - Page 1 of 5

  Sort by   
  Sorted by Rank Top-Bottom

Innovations in Combating Infectious Diseases: Opportunities in Therapeutics and Diagnostics through Application of Proteomics, Genomics, Nanotechnology, and Novel Sources of Lead Generation  
Business Insights, June 2010, Pages: 250
for many different infectious diseases but validation and commercialization has so far proved relatively elusive. - Drug resistance, emerging infections and the threat of bioterrorism make the understanding


Innovations in Molecular Diagnostics for Infectious Diseases  
Business Insights, Nov 2011, Pages: 168
testing market? - Who is developing new innovative products for the infectious disease MDx market and what paths to commercialization are they following? - How are the different sectors of the infectious


Molecular Diagnostics - Global Strategic Business Report  
Global Industry Analysts, Inc., Oct 2010, Pages: 659
Diagnosable 34 7. AN INSIGHT INTO APPLICATIONS OF MOLECULAR DIAGNOSTICS 35 Infectious Diseases Testing 35 Activity in the Field 35 Identifying Multidrug Resistance 36 Infectious Disease Treatment


Stakeholder Opinions: Tropical Diseases - Dengue, Japanese encephalitis and West Nile virus - Increasing attention for neglected diseases  
Datamonitor, Dec 2010, Pages: 204
encephalitis and West Nile virus in the seven major markets and its impact on commercial opportunities Overview Catalyst Summary About Datamonitor healthcare About the Infectious Disease pharmaceutical


Point of Care Testing: Evaluating the Return to Evidence Based Medicine, Novel Technologies and the Competitive Landscape  
Business Insights, Jan 2010, Pages: 283
Cardiology tests Infectious disease tests Drugs of abuse testing Clinical chemistry and other rapid tests Company profiles Market analysis and forecasts Chapter 1 Market overview Summary The shift


Novel Antibodies & Therapeutic Proteins: Technological Challenges & Future Prospects  
PharmaVision, Aug 2010, Pages: 183
- Immuno-inflammatory diseases - CNS diseases - Infectious diseases - Therapeutic proteins - Trends in personalised medicine - Commercial relevance - Delivery trends - Inhalation - Transdermals


Biomarkers, Tests and Trends for Drug R&D  
Takeda Pacific, Feb 2010, Pages: 144
and is Set for Growth - Cancer Biomarkers and Tests - Future Direction for CNS Disease Tests - Infectious Disease Testing 8.Appendices - WW Populations by Diseases - Examples of Uses of Biomarker Tests


Global Gene Therapy Market Analysis  
RNCOS E-Services Private Limited, Aug 2011, Pages: 105
in the segment. The companies will not only look to develop the therapies for various diseases through in-house research, but also develop the ones acquired from other sources into full-fledged commercial forms


Biopharmaceuticals - A Global Market Overview  
Industry Experts, April 2010, Pages: 240
.8.3.1 Oncology 1.8.3.2 Neurology 1.8.3.3 Diabetes 1.8.3.4 Infectious Diseases 1.8.3.5 Cardiovascular 1.8.3.6 Other Disease Areas 2. REGIONAL MARKET PERSPECTIVE 2.1 Regional Market Overview 2.1.1 North America 2


Stakeholder Insight: Hepatitis B & C in Asia - China, South Korea, Taiwan and Turkey  
Datamonitor, Feb 2010, Pages: 35
characteristics Demographics Economics Healthcare spend and access The hepatitis B and C market in Turkey BIBLIOGRAPHY Journal papers Websites Other About the Infectious Diseases analysis team Disclaimer


Stakeholder Opinions: Biologics in Infectious Diseases - Well Defined Target Populations are Key to Commercial Success  
Datamonitor, March 2008, Pages: 123
needs in the infectious diseases market and identify opportunities for antibody product development. - Gain an overview of the commercial outlook for antibody based products and their likely positioning


Fabry's Disease Therapeutics - Pipeline Assessment and Market Forecasts to 2018  
GlobalData, Dec 2011, Pages: 67
shaping and driving the global Fabry's Disease Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter


Infectious Diseases Vaccine Market Overview  
Datamonitor, Oct 2010, Pages: 196
key questions answered - Get a comprehensive, insightful commercial overview of the vaccines market - Learn about the strategies of the Big 5 players, their strengths, weaknesses, similarities


Stakeholder Opinions: Sexually Transmitted Diseases - An Underestimated Threat Lacking Interventions to Prevent Transmission  
Datamonitor, Aug 2010, Pages: 142
& Infectious Diseases pharmaceutical analysis team Executive Summary Scope of the analysis Datamonitor insight into the sexually transmitted diseases (STDs) market Related reports Upcoming related reports


Emerging Medical Sensing Technologies  
Frost & Sullivan, Sep 2008, Pages: 126
Viruses Low-Cost Portable Instrument for Testing Inhalable Drug Delivery Devices DNA-Based Sensors for Detecting Volatile Compounds TruArray for Rapid Diagnosis of Infectious Diseases A High-Performance


Biomarkers and Related Tests for Molecular Diagnostics and Pharma/ Biotech R&D -- Companies Products and WW Market, 2004-2009  
Takeda Pacific, July 2005, Pages: 168
Patterns and Profiles Measure Complex Diseases The Goal of `1-Cent-Per-SNP' Studies Protein Patterns Demonstrated as Biomarkers Making Diagnostics from Biomarkers Commercializing Biomarker Tests Home


Gene Therapy - Global Strategic Business Report  
Global Industry Analysts, Inc., Jan 2011, Pages: 442
Indication (2009): Percentage Breakdown of Number of Trials for Cancer Diseases, Cardiovascular Diseases, Infectious Diseases, Monogenic Diseases, Neurological Diseases and Others (includes corresponding


Biotechnology Industry 2010 Yearbook - Top Biologics, Biosimilars, Licensing and Financing, Mergers and Acquisitions  
GBI Research, Dec 2010, Pages: 198
of clinical need that are unmanageable with conventional therapeutics, such as oncology, infectious diseases including HIV, and autoimmune disorders. A strong product pipeline for most of the top 10


Emerging Medical Technologies Spotlight, a Report of Investment & Partnering Opportunities 2010  
Life Science Intelligence, Inc., Jan 2011
during meals - A fully integrated, affordable, sample-to-result platform for rapid, accurate PCR-based detection/differentiation of infectious disease - Pressure-controlled Intermittent Coronary Sinus


Beyond Expression Arrays: Emerging Applications for Genomic Microarray Technology  
Beachhead Consulting, Sep 2006
, splice variants, and microRNAs, combined with gene expression data, can be applied to the drug discovery process enabling many exciting applications, such as finding cures for infectious diseases


Results:  First -   Prev -   1 -   2 -   3 -   4 -   5 -   Next -   Last


For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds